Danaher Tops Earnings and Revenue Estimates. The Stock Is Rising.

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 6 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 6%
  • Publisher: 97%

Indonesia Berita Berita

Indonesia Berita Terbaru,Indonesia Berita utama

Danaher posts third-quarter earnings of $2.02 a share on revenue of $6.87 billion.

Danaher stock was rising Tuesday after the healthcare company reported third-quarter earnings and revenue that topped Wall Street estimates.

In the same period last year, the company reported earnings of $2.56 a share on revenue of $7.66 billion.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

 /  🏆 3. in İD
 

Terima kasih atas komentar Anda. Komentar Anda akan dipublikasikan setelah ditinjau.

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

FMC Stock Tumbles on Revenue Warning Ahead of EarningsThe crop protection company cited lower sales in Latin America as a reason for lowering estimates.
Sumber: MarketWatch - 🏆 3. / 97 Baca lebih lajut »

Agilysys’ stock jumps on revenue, earnings beatJon Swartz is a senior reporter for MarketWatch in San Francisco, covering many of the biggest players in tech, including Netflix, Facebook and Google. Jon has covered technology for more than 20 years, and previously worked for Barron's and USA Today. Follow him on Twitter jswartz.
Sumber: MarketWatch - 🏆 3. / 97 Baca lebih lajut »

3M Posts Big Earnings Beat Following Recent Legal SettlementsInvestors have reacted to 3M's flurry of announcements by essentially avoiding the stock.
Sumber: MarketWatch - 🏆 3. / 97 Baca lebih lajut »

Novartis lifts 2023 earnings forecast for third timeSwitzerland's Novartis (NOVN.S) on Tuesday raised its full-year earnings forecast for the third time, citing cost cuts and higher-than-forecast prices for a multiple sclerosis (MS) drug.
Sumber: Reuters - 🏆 2. / 97 Baca lebih lajut »